The Investment Column: Amersham sees hope of a cure
The change in "tone" in the industry, evident in the second half, is already boosting sales of Amersham's technology and services. Its drug development services, used in testing and screening new pharmaceuticals, molecular biology, where Amersham leads the market, and genetic sequencing, increasingly used by drugs groups to short-cut the search for new drugs, reported sales growth of between 10 and 17 per cent last year. The improvement helped return Amersham's main life sciences division to growth in the second half. But group profits up from pounds 47.3m to pounds 50.8m owed most of their growth to foreign exchange benefits, which added pounds 4.5m to the bottom line.
Healthcare, the pharmaceutical and diagnostic division, has continued to grow on the back of Amersham's already strong position in nuclear medicine. The main Ceretec brain imaging agent saw sales dip 8 per cent to pounds 22.3m under the onslaught of competition from Du Pont's Neurolite, but Metastron, for pain caused by bone cancer, now sells nearly as well and the hope for the future is Myoview, the heart imaging agent. Amersham will receive a boost to earnings from raising its stake in the Japanese Nihon Medi- Physics to 50 per cent from October and give it a third of the world market for nuclear medicine.
The omens are better than they have been for some time for Amersham, but even profits of pounds 63m this year would put the shares, up 28p at pounds 10.43, on a prospective p/e ratio of 17. Hold.
Wellcome Image Awards: The most striking images from the world of science, including breast cancer cells under chemical attack and a photographer’s own kidney stone
Missing Malaysia Airlines plane: 'All passengers' under investigation, police say
Bob Crow death: 'Admired by his members, feared by employers' - Tributes pour in for RMT union leader and 'working class hero' Bob Crow
Oscar Pistorius murder trial: Athlete repeatedly sick as court hears 'graphic details' of Reeva Steenkamp's post-mortem
How climate change helped Genghis Khan: Scientists believe a sudden period of warmer weather allowed the Mongols to invade with such success
Britain's top vet sparks controversy with call for ban on slashing animals' throats in 'ritual' slaughters for halal and kosher meat products
Poor 'live like animals' says Boris's privately educated sister after going on 'poverty safari'
Exclusive: Impact of immigrants on British workers ‘negligible’
Vince Cable: Teachers 'know absolutely nothing' about the world of work
Ukraine crisis: Russia pledges to 'retaliate against sanctions' as Ukrainian president says Crimea vote will not be recognised
The quiet diplomat: Catherine Ashton - recognised and admired in all the world’s troubled countries, yet ridiculed at home
- 1 Pakistan vs Paul Smith: Sandal-wearers bemused by famed British designer's attempts to sell traditional Peshawari chappal-style shoes for the distinctly untraditional sum of £300
- 2 Family forced to flee home after discovering 'terrifying' nest of spiders in bananas
- 3 Grace Dent: Who cares if she spells it Barraco Barner? Gemma Worrall is more employable than some bookish arts graduate
- 4 Russell Crowe's Noah banned in three Arab countries before worldwide premiere
- 5 Bob Crow death: 'Admired by his members, feared by employers' - Tributes pour in for RMT union leader and 'working class hero' Bob Crow
iJobs Money & Business
£1000 per month: Inspiring Interns: The company works with Tier 1 FTSE 100 Ban...
£35000 - £60000 per annum + Bonus + Benefits: Pro-Recruitment Group: You must ...
£60000 - £80000 per annum + BONUS + BENEFITS: Harrington Starr: A top, City ba...
VOLUNTARY ONLY - EXPENSES REIMBURSED : Reach Volunteering: Fantastic opportuni...